Navigation Links
AMDL, Inc. Names Douglas MacLellan as Executive Chairman & CEO
Date:11/5/2008

Michael Boswell nominated as Chairman of Audit committee

TUSTIN, Calif., Nov. 5 /PRNewswire-FirstCall/ -- (http://www.amdl.com) AMDL, Inc. (Amex: ADL), announced today Mr. Douglas MacLellan has been elected by its Board of Directors to the role of Chief Executive Officer and Executive Chairman effective immediately. Mr. Michael Boswell has been appointed to the Board and will assume Mr. MacLellan's former role as Chairman of AMDL's Audit committee and long-standing board member Dr. William Thompson will assume the role of Chairman of the Governance Committee.

"The board has great confidence in Mr. MacLellan and the Company's U.S. and China-based teams and we look forward to AMDL's continued success," commented long-time board member Dr. William Thompson. "Given Mr. MacLellan's decisive leadership, personal style, and more than 25 years of extensive business experience in China, Mr. MacLellan is fully prepared to lead AMDL to the next level. He is well-respected across the industry, specifically in China where the majority of AMDL's business is currently conducted. Equally important, Mr. MacLellan is highly-regarded by AMDL's U.S. and China-based teams. He is an absolute perfect fit for this role."

Mr. MacLellan is transitioning into his new role after nearly 16 years on AMDL's Board. He was appointed to the Board in 1992 and became Chairman of the Audit and Governance committees in 2001. Earlier this year he assumed the role of non-executive Chairman serving as an advisor and lead Company spokesperson for AMDL. He brings extensive international business experience to his new role, with a special focus on business operations and management in China where Mr. MacLella
'/>"/>

SOURCE AMDL, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. AMDL, Inc.s President & CEO Mr. Gary Dreher Retires
2. AMDL, Inc. Named to Deloitte LLC Technology Fast 50
3. AMDL, Inc. Announces Strategic Realignment
4. AMDL, Inc. to Present at Maxim Group Growth Conference October 7, 2008
5. AMDL, Inc. Closes Private Placement of Convertible Notes
6. The Wall Street Transcript Interviews AMDL, Inc. CEO & President Gary Dreher for Fall Healthcare Issue
7. Rudd Report Highlights AMDL, Inc.s Latest Business Achievements; Supports 2008 Financial Guidance
8. AMDL, Inc. Retains Strategic Growth International Inc. as its Global Investor Relations Advisor
9. BioAuthorize Holdings, Inc. Names New Directors and Executive and Unveils Modification to Its Voice Biometric Authentication Service
10. Sustainable Oils Names Scott Johnson as General Manager, Expands Management Team for Camelina Research and Production
11. PercSys Names David Auth and Howard Palefsky to Its Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2010)... surface for label-free biomolecular interaction analysis now offers surface ... Protein A and Protein G for coupling antibodies. ... ... CA (PRWEB) February 8, 2010 -- Silicon Kinetics Inc., ... the world,s first 3D biosensor surface for label-free biomolecular ...
(Date:2/8/2010)... and NEW ORLEANS , Feb. 8 ... a worldwide developer and marketer of diagnostic test kits, ... extension of the collaborative effort to combat viral hemorrhagic ... $800,000 in contract revenue for Corgenix over ... Institutes of Health (NIH) has awarded a five-year contract ...
(Date:2/8/2010)... the ClearTrial clinical services team to present the critical processes ... clinical development departments. , ... Chicago, ... of Clinical Trial Operations (CTO) software, today announced that both ... have been selected to speak at the CBI Forecasting & ...
(Date:2/8/2010)... , Feb. 8 /PRNewswire-Asia-FirstCall/ -- ... "the Company"), a leading China -based ... marketing,biopharmaceutical products, today announced a collaboration and ... and commercialize its,Nephoxil(R) pharmaceutical product for the ... Nephoxil (ferric citrate) ...
Breaking Biology Technology:Silicon Kinetics Announces New Biosensor Chips With Wide Palette of Surface Chemistries 2Corgenix and Tulane Announce Award of Additional NIH Contract to Expand Lassa Fever Research Towards Development of Vaccines and Improved Therapeutic Agents 2Corgenix and Tulane Announce Award of Additional NIH Contract to Expand Lassa Fever Research Towards Development of Vaccines and Improved Therapeutic Agents 3Corgenix and Tulane Announce Award of Additional NIH Contract to Expand Lassa Fever Research Towards Development of Vaccines and Improved Therapeutic Agents 4Corgenix and Tulane Announce Award of Additional NIH Contract to Expand Lassa Fever Research Towards Development of Vaccines and Improved Therapeutic Agents 5Corgenix and Tulane Announce Award of Additional NIH Contract to Expand Lassa Fever Research Towards Development of Vaccines and Improved Therapeutic Agents 6Corgenix and Tulane Announce Award of Additional NIH Contract to Expand Lassa Fever Research Towards Development of Vaccines and Improved Therapeutic Agents 7ClearTrial Selected to Provide Methodologies for Accurately Forecasting and Budgeting Clinical Spend and Integrated Financial Controls at CBI Conference 2ClearTrial Selected to Provide Methodologies for Accurately Forecasting and Budgeting Clinical Spend and Integrated Financial Controls at CBI Conference 3ClearTrial Selected to Provide Methodologies for Accurately Forecasting and Budgeting Clinical Spend and Integrated Financial Controls at CBI Conference 43SBio and Panacor Bioscience Enter Collaboration and License Agreement to Develop and Commercialize Nephoxil(R) for Hyperphosphatemia 23SBio and Panacor Bioscience Enter Collaboration and License Agreement to Develop and Commercialize Nephoxil(R) for Hyperphosphatemia 33SBio and Panacor Bioscience Enter Collaboration and License Agreement to Develop and Commercialize Nephoxil(R) for Hyperphosphatemia 4
... Kingdom,s lead centre for the developing technology to counter ... and Physical Sciences Research Council. , Almost 7m ... and Knowledge Centre - the Centre for Secure Information ... Institute of Electronics, Communications and Information Technology (ECIT) in ...
... VNUS(R) Medical,Technologies, Inc. (Nasdaq: VNUS ), a ... venous reflux disease, today announced its,plans to present at the ... 2008, at The New York Palace Hotel in New York ... Chief Executive,Officer. , VNUS, ...
... ARBOR, Mich., Nov. 21 MichBio, the association ... service providers to its fourth annual Expo on ... Financial ShowPlace in Novi, MI. The MichBio ... industry professionals.,In addition, this year,s event attracted 56 ...
Other Biology Technology:Queen's secures £25M for UK's cyber safety 2MichBio Expo Draws Nearly 500 Professionals; Career Day Raises Profile 2MichBio Expo Draws Nearly 500 Professionals; Career Day Raises Profile 3
(Date:2/9/2010)... the Hood Center for Children and Families at Dartmouth ... on the significant potential negative impact that food product ... , The study, which appears in the current edition ... of the "brand placements" for food, beverage, and food ... for energy-dense, nutrient-poor foods or product lines. In addition, ...
(Date:2/9/2010)... The Scripps Research Institute have discovered a potential new ... for sheep and cattle infected with liver fluke. The ... in combating river blindness, a tropical disease that is ... humans. , The study is scheduled for publication ... Proceedings of the National Academy of Sciences ...
(Date:2/9/2010)... they say is a strong candidate for involvement in ... the natural flux in hormones during the menstrual cycle. ... of the National Academy of Sciences , Rockefeller University ... human variant of the gene increases anxiety, dampens curiosity ... impairing memory. If applied in the clinic, the work ...
Breaking Biology News(10 mins):New study examines the impact on children of food product placements in the movies 2New study examines the impact on children of food product placements in the movies 3Scripps research team reveals how an old drug could have a new use for treating river blindness 2Scripps research team reveals how an old drug could have a new use for treating river blindness 3Scripps research team reveals how an old drug could have a new use for treating river blindness 4Research identifies gene with likely role in premenstrual disorder 2Research identifies gene with likely role in premenstrual disorder 3GAA Calls on President Obama to Make Good on His Nobel Peace Prize Speech 63059 1GAA Calls on President Obama to Make Good on His Nobel Peace Prize Speech 63059 2West Coast Banks Salem Battle Creek Branch is Collecting Teddy Bears for Sick Children at the Salem Hospital 63054 1Successful Stem Cell Therapy for Treatment of Eye Disease 15140 1Successful Stem Cell Therapy for Treatment of Eye Disease 15140 2Successful Stem Cell Therapy for Treatment of Eye Disease 15140 3Successful Stem Cell Therapy for Treatment of Eye Disease 15140 4
... at the Case Western Reserve University School of Medicines ... impacting the three billion people exposed to malaria every ... D., and Christopher L. King, M.D., Ph.D. published in ... (PLoS Medicine), novel findings proving new antibodies inhibit infection ...
... times as likely as U.S-born children to suffer from lead ... Department study, and the risk is highest among the most ... poisoning in 2002, published online in the American Journal of ... abroad within the previous six months were 11 times as ...
... -- Two deadly and highly infectious viruses -- both potential ... new drug developed by scientists at Weill Cornell Medical College ... related, newly recognized zoonotic viruses that can spread from their ... pigs, horses and humans. , The mode of transmission ...
Other Biology News:CWRU School of Medicine has evidence vaccine against malaria will reduce disease 2Study shows immigrant children are at increased risk of lead poisoning 2Study shows immigrant children are at increased risk of lead poisoning 3Drug aimed at 2 bioterror agents blocks live viral infection, Weill Cornell team reports 2Drug aimed at 2 bioterror agents blocks live viral infection, Weill Cornell team reports 3
... LC Sciences provides a genome-wide microRNA (miRNA) ... proprietary probe design, which enable highly sensitive ... We have standard arrays for mature miRNA ... version of the Sanger miRBase database (Release ...
... studies, vaccine development, and biosensor development ... Paraflo microfluidic on-chip synthesis platform. These ... our comprehensive Epitope Peptide Microarray Service. ... Probe content is completely customer specified. ...
... peptide microarrays designed for quantitative assays ... and built on the flexible and ... of customer specified sequences can be ... provide assistance with custom sequence design. ...
... first time, you can identify and characterize ... without interferences. The Agilent Multiple Affinity Removal ... high-abundant proteins from human serum, plasma, CSF ... device. With this revolutionary system, you can: ...
Biology Products: